PubMed · 2392146
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
D Gershon. 1990-08-30. Genetic engineering. Tryptophan under suspicion.. https://doi.org/10.1038/346787a0
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
NARES is a clinical syndrome consisting of symptoms consistent with AR in which an absence of atopy has been demonstrated by allergen skin testing, with nasal cytology analysis showing greater than 20% eosinophils. Anosmia is a prominent feature not shared with AR. The pathophysiology of NARES is poorly understood, but a key component involves a self-perpetuating, chronic eosinophilic nasal inflammation with development of nasal micropolyposis and polyposis. Mast cells likely play an important role as well. NARES is a risk factor for the development of nasal polyposis and aspirin sensitivity, as well as obstructive sleep apnea. Treatment consists mainly of intranasal corticosteroids with or without the addition of second-generation antihistamines and/or LT receptor antagonists as an adjuvant.
Explore the source record for details and available documents.
Explore the source record for details and available documents.